Cancer Research and Treatment

Case Report

PTEN Mutation Identified in Patient Diagnosed with Simultaneous Multiple Cancers: Hye Sung Won, Eun Deok Chang, Sae Jung Na, In Yong Whang, Dong Soo Lee, Sun Hyong You, Yong Seok Kim, Jeong Soo Kim; Cancer Res Treat. 2019;51(1):402-407. Published online February 27, 2018; DOI: https://doi.org/10.4143/crt.2017.579

PTEN hamartoma tumor syndrome is a spectrum of disorders characterized by unique phenotypic features including multiple hamartomas caused by mutations of the tumor suppressor gene PTEN. Cowden syndrome and Bannayan–Riley–Ruvalcaba syndrome are representative diseases, and both have several common clinical features and differences. Because PTEN mutations are associated with an increased risk of malignancy including breast, thyroid, endometrial, and renal cancers, cancer surveillance is an important element of disease management. We report a germline mutation of the PTEN (c.723dupT, exon 7) identified in a young woman with a simultaneous occurrence of breast cancer, dermatofibrosarcoma protuberans, and follicular neoplasm. This case suggests that it is critical for clinicians to recognize the phenotypic features associated with these syndromes to accurately diagnose them and provide preventive care.

Citations

Citations to this article as recorded by

Breast Cancer with a Newly Diagnosed Variant in the PTEN Gene: A Case Report
Yuka Maeda, Tatsuhiko Ikeda, Ayana Sato, Akiko Matsumoto, Hiromitsu Jinno
Surgical Case Reports.2025; 11(1): n/a. CrossRef
Synchronous and metachronous thyroid cancer, breast cancer, and melanoma in a premenopausal patient with Cowden syndrome
Belinda Asare, Babita Panigrahi
Radiology Case Reports.2023; 18(5): 1918. CrossRef
Molecular Action of Herbal Antioxidants in Regulation of Cancer Growth: Scope for Novel Anticancer Drugs
Manjula Vinayak
Nutrition and Cancer.2018; 70(8): 1199. CrossRef

8,588 View
277 Download
2 Web of Science
3 Crossref

First
Prev
Page of 1
Next
Last

Search